Point-of-care troponin testing plays a crucial role in the nursing assessment of patients presenting with chest pain. This review article aims to explore the significance of utilizing point-of-care troponin testing in the early assessment of patients with chest pain in various healthcare settings. Troponin is a cardiac biomarker that is released into the bloodstream following myocardial injury, making it a valuable tool for diagnosing acute coronary syndromes. The availability of point-of-care troponin testing allows for rapid and accurate assessment of troponin levels, enabling nurses to make timely clinical decisions and improve patient outcomes. Nurses are often the first point of contact for patients presenting with chest pain, and their role in triaging and assessing these patients is critical. Point-of-care troponin testing empowers nurses to quickly determine whether a patient is experiencing a cardiac event, facilitating prompt initiation of appropriate interventions. Furthermore, the integration of point-of-care troponin testing into nursing practice enhances the efficiency of patient care by reducing turnaround times for troponin results and expediting decision-making processes. In addition to its role in the initial assessment of patients with chest pain, point-of-care troponin testing also plays a vital role in ongoing laboratory monitoring. Serial troponin measurements are essential for evaluating changes in troponin levels over time, which can provide valuable insights into a patient's cardiac status and response to treatment. By incorporating point-of-care troponin testing into routine nursing care, healthcare providers can closely monitor troponin trends and adjust treatment plans accordingly. This review article highlights the importance of integrating point-of-care troponin testing into nursing practice for the assessment of patients with chest pain and ongoing laboratory monitoring. By leveraging the benefits of rapid troponin testing at the point of care, nurses can enhance the quality of care provided to patients with suspected cardiac conditions and contribute to improved patient outcomes.